Jessica Rosalia, RCSWI | |
654 Se Monterey Rd, Stuart, FL 34994-4410 | |
(772) 247-7147 | |
Not Available |
Full Name | Jessica Rosalia |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 654 Se Monterey Rd, Stuart, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184498883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | SW22499 (Florida) | Primary |
Entity Name | Grow Healthcare Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245845932 PECOS PAC ID: 3476961368 Enrollment ID: O20210414000053 |
News Archive
The team identified beta-sitosterol - a steroid that can inhibit the absorption of cholesterol in the intestine - as the main constituent of pomegranate seed extract. The research suggests that pomegranate extract could be used as a natural stimulant to encourage the uterus to contract during labour.
A new vaccine principle is being developed by scientists at the University of Copenhagen which - if it works to its full expected potential - could help to save millions of lives and revolutionise current vaccine technology.
There might be a simpler and less expensive method of controlling the progression of HIV, according to several preliminary studies presented last Thursday at the XVI International AIDS Conference in Toronto, the Los Angeles Times reports (Chong, Los Angeles Times, 8/18).
Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.- in association with the Medco Research Instituteā¢ - and Mayo Clinic announced today.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Jessica Rosalia, RCSWI 6391 Se Windsong Ln # 139, Stuart, FL 34997-8238 Ph: (561) 685-1822 | Jessica Rosalia, RCSWI 654 Se Monterey Rd, Stuart, FL 34994-4410 Ph: (772) 247-7147 |
News Archive
The team identified beta-sitosterol - a steroid that can inhibit the absorption of cholesterol in the intestine - as the main constituent of pomegranate seed extract. The research suggests that pomegranate extract could be used as a natural stimulant to encourage the uterus to contract during labour.
A new vaccine principle is being developed by scientists at the University of Copenhagen which - if it works to its full expected potential - could help to save millions of lives and revolutionise current vaccine technology.
There might be a simpler and less expensive method of controlling the progression of HIV, according to several preliminary studies presented last Thursday at the XVI International AIDS Conference in Toronto, the Los Angeles Times reports (Chong, Los Angeles Times, 8/18).
Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.- in association with the Medco Research Instituteā¢ - and Mayo Clinic announced today.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
› Verified 5 days ago
Andrea Greenlee, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 900 Se Ocean Blvd Ste 340e, Stuart, FL 34994 Phone: 772-220-3439 Fax: 772-220-3484 | |
Frances Palmer Holliday, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 135 Se Martin Ave, Stuart, FL 34996 Phone: 772-341-3431 | |
Marissa Scimeca, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1100 Se Federal Hwy, Stuart, FL 34994 Phone: 772-320-0791 Fax: 772-320-0181 | |
Ms. Leigh Stewart Hayden, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 828 Sw Palm City Rd, Stuart, FL 34994 Phone: 772-341-7337 Fax: 772-678-6513 | |
Mrs. Tracy Marie Zboril, MSW LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 51 Sw Flagler Ave, #203, Stuart, FL 34994 Phone: 772-221-0407 Fax: 772-220-4376 | |
Meranda Mccreary, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1100 Se Federal Hwy, Stuart, FL 34994 Phone: 772-320-0770 | |
Rosana Zapata, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 735 Colorado Ave, Suite 6, Stuart, FL 34994 Phone: 772-220-3439 |